End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.11 CNY | -1.73% |
|
-6.07% | -52.60% |
06-25 | Yahong Meditech to Trial Drug Against Amoebae Infection | MT |
06-17 | ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with Asieris Pharmaceuticals | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-52.60% | 408M | |
+16.14% | 122B | |
+19.66% | 113B | |
+18.95% | 26.49B | |
-24.11% | 19.4B | |
-19.03% | 16.24B | |
-20.45% | 15.4B | |
-46.14% | 15.15B | |
+63.71% | 14.93B | |
+4.39% | 13.52B |
- Stock Market
- Equities
- 688176 Stock
- News Jiangsu Yahong Meditech Co., Ltd.
- Yahong Meditech to Trial Drug Against Amoebae Infection